AGENUS INC Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements
AGENUS INC (AGEN) reported Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements of 0 shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes
us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements · last filed 2026-08-07
- AGENUS INC incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2026-06-30 was 0.00 shares.
- AGENUS INC incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2026-03-31 was 341.00K shares.
- AGENUS INC incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2025-09-30 was 914.00K shares.
- AGENUS INC incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2025-06-30 was 0.00 shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 3 month | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 6 month | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 9 month |
|---|---|---|---|
| 2026-06-30 | 0.00 shares 10-Q · filed 2026-08-07 | 453.00K shares 10-Q · filed 2026-08-07 | |
| 2026-03-31 | 341.00K shares 10-Q · filed 2026-05-11 | ||
| 2025-09-30 | 914.00K shares 10-Q · filed 2025-11-10 | 22.00K shares 10-Q · filed 2025-11-10 | |
| 2025-06-30 | 0.00 shares 10-Q · filed 2026-08-07 | 0.00 shares 10-Q · filed 2026-08-07 | |
| 2025-03-31 | 0.00 shares 10-Q · filed 2026-05-11 | ||
| 2024-09-30 | 0.00 shares 10-Q · filed 2025-11-10 | 0.00 shares 10-Q · filed 2025-11-10 | |
| 2021-09-30 | 7.97M shares 10-Q · filed 2022-11-08 | 4.43M shares 10-Q · filed 2022-11-08 | |
| 2019-03-31 | 1.50M shares 10-Q · filed 2020-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |